博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300318 博晖创新

已收盘 07-23 15:00:00

{"stockData":{"symbol":"300318","market":"SZ","secType":"STK","nameCN":"博晖创新","latestPrice":6.16,"timestamp":1753254192000,"preClose":6.19,"halted":0,"volume":9486598,"delay":0,"changeRate":-0.0048,"floatShares":799000000,"shares":817000000,"eps":-0.018,"marketStatus":"已收盘","change":-0.03,"latestTime":"07-23 15:00:00","open":6.18,"high":6.24,"low":6.14,"amount":58678200,"amplitude":0.0162,"askPrice":6.17,"askSize":400,"bidPrice":6.16,"bidSize":2280,"shortable":0,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.19,"symbolType":"stock","openAndCloseTimeList":[[1753234200000,1753241400000],[1753246800000,1753254000000]],"highLimit":6.81,"lowLimit":5.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":816900495,"isCdr":false,"pbRate":3.68,"roa":"--","roe":"--","epsLYR":0.0113,"committee":0.355053,"marketValue":5032000000,"turnoverRate":0.0119,"status":1,"floatMarketCap":4919000000},"requestUrl":"/m/hq/s/300318","defaultTab":"news","newsList":[{"id":"2549856771","title":"血液制品概念盘中拉升，博晖创新涨1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549856771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549856771?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:36","pubTimestamp":1751938615,"startTime":"0","endTime":"0","summary":"07月08日，血液制品概念盘中拉升，截至09点36分，血液制品概念整体指数上涨0.51%，报833.350点。从个股上来看，该概念的成分股中，博晖创新涨1.68%，科华生物、赛伦生物、华兰生物涨幅居前。从资金上来看，截止发稿，血液制品概念概念主力净流入为-3336.30万，其中上海莱士受到资金热捧，主力净流入45.90万；拉长时间线来看，该板块近20日主力资金净流入-8.60亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093655953a3446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708093655953a3446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","688163","BK0239","300318","BK0251","BK0048"],"gpt_icon":0},{"id":"2548437337","title":"生物制品行业盘中跳水，博晖创新跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548437337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548437337?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:55","pubTimestamp":1751594114,"startTime":"0","endTime":"0","summary":"07月04日，生物制品行业盘中跳水，截至09点55分，生物制品行业整体指数下跌0.51%，报6314.560点。从个股上来看，该行业的成分股中，博晖创新跌0.17%，跌幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为-1.27亿，其中荣昌生物受到资金热捧，主力净流入3930.08万；拉长时间线来看，该板块近20日主力资金净流入-25.74亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070409551497994af3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070409551497994af3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1064131003.USD","BK0239","BK0251","BK0028","LU1064130708.USD","LU2488822045.USD","300318","688331","LU2148510915.USD","BK0048"],"gpt_icon":0},{"id":"2539282612","title":"博晖创新最新公告：获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2539282612","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539282612?lang=zh_cn&edition=full","pubTime":"2025-05-30 17:51","pubTimestamp":1748598688,"startTime":"0","endTime":"0","summary":"博晖创新(300318.SZ)公告称，公司近日获得国家药品监督管理局颁发的医疗器械注册证，产品名称为轮状病毒、诺如病毒、肠道腺病毒、星状病毒和札如病毒核酸检测试剂盒（PCR-荧光探针法），注册分类为Ⅲ类，注册证编号为国械注准20253401042，有效期至2030年5月28日。该产品用于体外定性检测腹泻患者粪便样本中的多种病毒核酸，丰富了公司产品种类，提升核心竞争力和市场拓展能力，但实际销售情况受市场推广效果等因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053000028854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318","BK0028","BK0251","09997","BK1583","BK1100","BK1222","BK1574","BK0048","09996","159883"],"gpt_icon":0},{"id":"2531712847","title":"博晖创新（300318）2025年一季报简析：净利润减120.41%，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2531712847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531712847?lang=zh_cn&edition=full","pubTime":"2025-04-30 07:07","pubTimestamp":1745968076,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博晖创新发布2025年一季报。截至本报告期末，公司营业总收入2.02亿元，同比下降23.05%，归母净利润-405.44万元，同比下降120.41%。本报告期博晖创新应收账款上升，应收账款同比增幅达54.38%。去年的净利率为1.02%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000009169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"gpt_icon":0},{"id":"2530424700","title":"博晖创新(300318.SZ)发布一季度业绩，由盈转亏至405.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530424700","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530424700?lang=zh_cn&edition=full","pubTime":"2025-04-28 17:12","pubTimestamp":1745831520,"startTime":"0","endTime":"0","summary":"博晖创新(300318.SZ)发布2025年第一季度报告，该公司营业收入为2.02亿元，同比减少23.05%。归属于上市公司股东的净亏损为405.44万元。归属于上市公司股东的扣除非经常性损益的净亏损为494.17万元。基本每股亏损为0.005元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-28/doc-ineutiys5131999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0251","300318","BK0048"],"gpt_icon":0},{"id":"2530844560","title":"博晖创新2024年财报：营收下滑18.53%，净利润扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2530844560","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530844560?lang=zh_cn&edition=full","pubTime":"2025-04-28 14:36","pubTimestamp":1745822186,"startTime":"0","endTime":"0","summary":"2025年4月28日，博晖创新发布了2024年年报。检验检测业务：收入下滑12.12%，HPV产品受集采影响博晖创新的检验检测业务在2024年实现主营业务收入24,013.03万元，同比下降12.12%。生物制品业务：收入下降20.5%，血液制品销量减少博晖创新的生物制品业务在2024年实现主营业务收入57,692.25万元，同比下降20.5%。总体来看，博晖创新在2024年虽然实现了净利润的扭亏为盈，但营收下滑、现金流紧张以及存货增加等问题仍然不容忽视。","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2025/04/cms_20250428144454215.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/04/cms_20250428144454215.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/28143649945562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300318"],"gpt_icon":0},{"id":"2530172098","title":"博晖创新（300318）2024年年报简析：净利润增137.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530172098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530172098?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:38","pubTimestamp":1745707089,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博晖创新发布2024年年报。根据财报显示，博晖创新净利润增137.09%。截至本报告期末，公司营业总收入8.52亿元，同比下降18.53%，归母净利润924.6万元，同比上升137.09%。去年的净利率为1.02%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700001954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"gpt_icon":0},{"id":"2530142864","title":"博晖创新(300318)3月31日股东户数3.01万户，较上期减少2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530142864","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530142864?lang=zh_cn&edition=full","pubTime":"2025-04-26 17:14","pubTimestamp":1745658891,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博晖创新披露，截至2025年3月31日公司股东户数为3.01万户，较12月31日减少799.0户，减幅为2.58%。在生物制品行业个股中，博晖创新股东户数低于行业平均水平，截至3月31日，生物制品行业平均股东户数为3.38万户。从股价来看，2024年12月31日至2025年3月31日，博晖创新区间跌幅为3.85%，在此期间股东户数减少799.0户，减幅为2.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600012019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300318","BK0048","BK0028"],"gpt_icon":0},{"id":"2528755182","title":"博晖创新上涨10.63%，报6.97元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528755182","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528755182?lang=zh_cn&edition=full","pubTime":"2025-04-17 13:54","pubTimestamp":1744869280,"startTime":"0","endTime":"0","summary":"4月17日，博晖创新盘中上涨10.63%，截至13:54，报6.97元/股，成交2.56亿元，换手率4.94%，总市值56.94亿元。截至9月30日，博晖创新股东户数3.38万，人均流通股2.37万股。2024年1月-9月，博晖创新实现营业收入6.46亿元，同比减少19.85%；归属净利润2371.77万元，同比增长67.77%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/17135449613921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","BK0028","BK0048","300318"],"gpt_icon":0},{"id":"2518577756","title":"博晖创新：云南血制工厂已建设完毕正推进产品工艺验证等各项工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2518577756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518577756?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:36","pubTimestamp":1741664198,"startTime":"0","endTime":"0","summary":"公司云南血制工厂已经建设完毕，正按照《药品上市后变更管理办法》等相关规范性文件和变更技术指导原则要求，陆续推进产品工艺验证、药品上市许可持有人变更、生产场地及药学研究、变更批复等各项工作；目前人白和静丙的变更申请已经获CDE受理，正在评审过程中。云南血制工厂的设备设施均按照规定进行维护和验证，目前状态正常。由于云南工厂还未投产，相关设备尚未开始折旧。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100017291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0028","300318","BK0048"],"gpt_icon":0},{"id":"2513514732","title":"博晖创新：公司体外诊断检测试剂所使用的微流控芯片由公司研发制造","url":"https://stock-news.laohu8.com/highlight/detail?id=2513514732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513514732?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:00","pubTimestamp":1740128420,"startTime":"0","endTime":"0","summary":"证券之星消息，博晖创新(300318)02月21日在投资者关系平台上答复投资者关心的问题。投资者：检测的芯片不是自主研发的么？博晖创新董秘：尊敬的投资者，您好！公司体外诊断检测试剂所使用的微流控芯片由公司研发制造，主要用途为液体试剂载体，通过仪器气路模块驱动芯片上的泵阀实现液体试剂在芯片中的定向流动，完成样本的提取、PCR扩增、DNA反向杂交等检测过程。微流控芯片与公司的检测分析仪器配套使用，实现分子诊断试剂的自动化检测。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100028224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159813","300318","BK0048","BK0251"],"gpt_icon":0},{"id":"2512167344","title":"博晖创新最新公告：控股孙公司联合获得三价流感病毒亚单位疫苗药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2512167344","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512167344?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:03","pubTimestamp":1740042185,"startTime":"0","endTime":"0","summary":"博晖创新公告，公司控股孙公司博晖生物制药股份有限公司与北京百晖生物科技有限公司联合申报的三价流感病毒亚单位疫苗获得国家药品监督管理局出具的《药物临床试验批准通知书》，同意开展临床试验。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000027651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0028","BK0048","BK0251","03347","300318","BK1583","BK1141","BK1576"],"gpt_icon":0},{"id":"2512418252","title":"博晖创新(300318.SZ)：三价流感病毒亚单位疫苗临床试验获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2512418252","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512418252?lang=zh_cn&edition=full","pubTime":"2025-02-20 16:18","pubTimestamp":1740039510,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博晖创新(300318.SZ)公告，公司控股孙公司博晖生物制药股份有限公司(简称“廊坊博晖”)与北京百晖生物科技有限公司(简称“百晖生物”)联合申报的三价流感病毒亚单位疫苗，获得国家药品监督管理局出具的《药物临床试验批准通知书》，同意开展临床试验。公告显示，廊坊博晖与百晖生物联合申报的三价流感病毒亚单位疫苗，通过高度纯化的病毒表面抗原(如血凝素HA和神经氨酸酶NA)刺激机体产生免疫反应，用于预防疫苗相关型别的流感病毒引起的流行性感冒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0048","BK1141","BK1583","300318","BK0251","159646","03347","BK1576","BK0028"],"gpt_icon":0},{"id":"2505105972","title":"博晖创新最新公告：控股子公司下属浆站取得单采血浆许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2505105972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505105972?lang=zh_cn&edition=full","pubTime":"2025-01-21 16:26","pubTimestamp":1737447994,"startTime":"0","endTime":"0","summary":"博晖创新公告，公司控股子公司广东卫伦生物制药有限公司下属和林格尔县卫伦单采血浆有限公司和土默特左旗卫伦单采血浆有限公司取得内蒙古自治区卫生健康委员会颁发的《单采血浆许可证》，准予执业。和林格尔浆站和土默特左旗浆站的业务项目均为原料血浆的采集与供应，设置单采血浆站的血液制品生产单位为广东卫伦生物制药有限公司，采浆区域分别为和林格尔县和土默特左旗城内，有效期限均自2025年1月15日至2027年1月14日。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100025264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300318","BK0028","BK0251"],"gpt_icon":0},{"id":"2505148932","title":"博晖创新(300318.SZ)控股子公司下属浆站取得单采血浆许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2505148932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505148932?lang=zh_cn&edition=full","pubTime":"2025-01-21 15:45","pubTimestamp":1737445520,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博晖创新(300318.SZ)发布公告，近日，公司控股子公司广东卫伦生物制药有限公司下属和林格尔县卫伦单采血浆有限公司(以下简称“和林格尔浆站”)和土默特左旗卫伦单采血浆有限公司(以下简称“土默特左旗浆站”)取得内蒙古自治区卫生健康委员会颁发的《单采血浆许可证》，和林格尔浆站和土默特左旗浆站经核准登记，准予执业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0048","300318","BK0251","BK0028"],"gpt_icon":0},{"id":"2504748901","title":"博晖创新新提交“博晖创新”、“博晖生物”等4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2504748901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504748901?lang=zh_cn&edition=full","pubTime":"2025-01-19 04:56","pubTimestamp":1737233802,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日北京博晖创新生物技术集团股份有限公司新提交“博晖创新”、“博晖生物”等4件商标注册申请。商标申请详情如下：今年以来北京博晖创新生物技术集团股份有限公司新申请注册商标4件，截止目前公司共持有注册商标40件，另有16件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011900000115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0028","300318","BK0251"],"gpt_icon":0},{"id":"2501628340","title":"博晖创新收盘上涨3.34%，最新市净率3.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2501628340","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501628340?lang=zh_cn&edition=full","pubTime":"2025-01-06 17:33","pubTimestamp":1736155993,"startTime":"0","endTime":"0","summary":"1月6日，博晖创新今日收盘5.57元，上涨3.34%，最新市净率3.27。截至2024年三季报，共有1家机构持仓博晖创新，其中其他1家，合计持股数547.16万股，持股市值0.33亿元。北京博晖创新生物技术集团股份有限公司的主营业务为检验检测业务及生物制品业务。公司主要产品有HPV检测产品、微量元素检测产品、质谱相关检测产品、其他耗材及服务、人血白蛋白、静注人免疫球蛋白、其他血液制品。最新一期业绩显示，2024年三季报，公司实现营业收入6.46亿元，同比-19.85%；净利润2371.77万元，同比67.77%，销售毛利率50.65%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/06173347160497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300318","BK0028","BK0048","BK0251"],"gpt_icon":0},{"id":"2487593079","title":"博晖创新获得外观设计专利授权：“核酸检测仪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2487593079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487593079?lang=zh_cn&edition=full","pubTime":"2024-11-30 02:26","pubTimestamp":1732904813,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示博晖创新新获得一项外观设计专利授权，专利名为“核酸检测仪”，专利申请号为CN202430189104.6，授权日为2024年11月29日。今年以来博晖创新新获得专利授权6个，较去年同期增加了200%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024113000003675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300318","BK0048","BK0251"],"gpt_icon":0},{"id":"2479760036","title":"博晖创新（300318）2024年三季报简析：净利润增67.77%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479760036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479760036?lang=zh_cn&edition=full","pubTime":"2024-10-31 06:40","pubTimestamp":1730328053,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博晖创新发布2024年三季报。截至本报告期末，公司营业总收入6.46亿元，同比下降19.85%，归母净利润2371.77万元，同比上升67.77%。本报告期博晖创新盈利能力上升，毛利率同比增幅13.32%，净利率同比增幅125.14%。去年的净利率为1.5%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100009333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300318"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753269942109,"stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0879},{"period":"3month","weight":-0.0521},{"period":"6month","weight":0.1275},{"period":"1year","weight":0.2633},{"period":"ytd","weight":0.0822}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京博晖创新生物技术集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"30146人(较上一季度减少2.58%)","perCapita":"26489股","listingDate":"2012-05-23","address":"北京市昌平区生命园路9号院","registeredCapital":"81690万元","survey":"　　北京博晖创新生物技术集团股份有限公司的主营业务是体外诊断产品的研发、生产与销售。公司的主要产品是检测仪器、检测软件、检测试剂、校准品、质控品、国家标准物质。","listedPrice":15},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博晖创新,300318,博晖创新股票,博晖创新股票老虎,博晖创新股票老虎国际,博晖创新行情,博晖创新股票行情,博晖创新股价,博晖创新股市,博晖创新股票价格,博晖创新股票交易,博晖创新股票购买,博晖创新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}